Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shangqing Ren

Showing results (21-30 of 56) with videos related to

Pageof 6
Sort By:
BMC Surgery|June 19, 2026
Correction: Analysis of preoperative nutrition, immunity and inflammation correlation index on the prognosis of upper tract urothelial carcinoma surgical patients: a retrospective single center studyYong Ou, Yang Zheng, Dong Wang, et al.
European Urology|May 15, 2022
Re: Longbin Xiong, Jane K. Nguyen, Yulu Peng, et al. What Happens to the Preserved Renal Parenchyma After Clamped Partial Nephrectomy? Eur Urol. 2022;81:492-500. https://doi.org/10.1016/j.eururo.2021.12.036Shangqing Ren, Shan Zhong, Shida Fan, et al.
Medicine|November 29, 2024
Partial nephrectomy versus radiofrequency ablation in patients with cT1a renal cell carcinoma: A surveillance, epidemiology, end results (SEER) analysisBo Yang, Yang Zheng, Mengqin Zheng, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|March 19, 2023
Recent advances in single-site/incision robotic-assisted radical prostatectomyShangqing Ren, Yang Zheng, Xu Hu, et al.
Frontiers in Pharmacology|June 16, 2023
Progress and prospects of targeted therapy and immunotherapy for urachal carcinomaYang Zheng, Heling Peng, Xu Hu, et al.
Frontiers in Pharmacology|July 11, 2024
Adverse renal outcomes following targeted therapies in renal cell carcinoma: a systematic review and meta-analysisSong Ren, Xiuling Chen, Yang Zheng, et al.
Frontiers in Endocrinology|May 14, 2023
Relationship between weight-adjusted-waist index and erectile dysfunction in the United State: results from NHANES 2001-2004Shangqi Cao, Xu Hu, Yanxiang Shao, et al.
British Journal of Cancer|June 18, 2024
CDK4/6 inhibitors dephosphorylate RNF26 to stabilize TSC1 and increase the sensitivity of ccRCC to mTOR inhibitorsXinlin Liu, Wei Li, Lu Yi, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|March 23, 2023
Radical versus partial nephrectomy for T1 non-clear cell renal cell carcinomaXu Hu, Yaohui Wang, Yanxiang Shao, et al.
Journal of Robotic Surgery|May 3, 2024
Comparison of perioperative and functional outcomes of single-incision versus standard multi-incision robot-assisted laparoscopic radical prostatectomy: a prospective, controlled, nonrandomized trialShida Fan, Zhengjun Chen, Fang Zhou, et al.
Pageof 6

Showing results (21-30 of 56) with videos related to

Sort By:
Pageof 6
BMC Surgery|June 19, 2026
Correction: Analysis of preoperative nutrition, immunity and inflammation correlation index on the prognosis of upper tract urothelial carcinoma surgical patients: a retrospective single center studyYong Ou, Yang Zheng, Dong Wang, et al.
European Urology|May 15, 2022
Re: Longbin Xiong, Jane K. Nguyen, Yulu Peng, et al. What Happens to the Preserved Renal Parenchyma After Clamped Partial Nephrectomy? Eur Urol. 2022;81:492-500. https://doi.org/10.1016/j.eururo.2021.12.036Shangqing Ren, Shan Zhong, Shida Fan, et al.
Medicine|November 29, 2024
Partial nephrectomy versus radiofrequency ablation in patients with cT1a renal cell carcinoma: A surveillance, epidemiology, end results (SEER) analysisBo Yang, Yang Zheng, Mengqin Zheng, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|March 19, 2023
Recent advances in single-site/incision robotic-assisted radical prostatectomyShangqing Ren, Yang Zheng, Xu Hu, et al.
Frontiers in Pharmacology|June 16, 2023
Progress and prospects of targeted therapy and immunotherapy for urachal carcinomaYang Zheng, Heling Peng, Xu Hu, et al.
Frontiers in Pharmacology|July 11, 2024
Adverse renal outcomes following targeted therapies in renal cell carcinoma: a systematic review and meta-analysisSong Ren, Xiuling Chen, Yang Zheng, et al.
Frontiers in Endocrinology|May 14, 2023
Relationship between weight-adjusted-waist index and erectile dysfunction in the United State: results from NHANES 2001-2004Shangqi Cao, Xu Hu, Yanxiang Shao, et al.
British Journal of Cancer|June 18, 2024
CDK4/6 inhibitors dephosphorylate RNF26 to stabilize TSC1 and increase the sensitivity of ccRCC to mTOR inhibitorsXinlin Liu, Wei Li, Lu Yi, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|March 23, 2023
Radical versus partial nephrectomy for T1 non-clear cell renal cell carcinomaXu Hu, Yaohui Wang, Yanxiang Shao, et al.
Journal of Robotic Surgery|May 3, 2024
Comparison of perioperative and functional outcomes of single-incision versus standard multi-incision robot-assisted laparoscopic radical prostatectomy: a prospective, controlled, nonrandomized trialShida Fan, Zhengjun Chen, Fang Zhou, et al.
Pageof 6